The Clinical Story of CCM® – Looking ahead to HFpEF Population

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of patients with any cardiovascular disease to include devices, drugs, and digital health care products listed below:

• Consultant Fee/Honoraria/Speaker's Bureau (Personal) - AstraZeneca; Bayer AG; Abbott; Medtronic; Merck/Schering Plough; Adrenomed; Applied Therapeutics; Array; Boehringer Ingelheim; CVRx; G3 Pharma; Impulse Dynamics; Innolife; Janssen; LivaNova; Luitpold; Novartis; NovoNordisk; Relypsa; Sequana Medical; Vifor
• Grant Support/Research Contract (Personal) - Amgen